For patients with T2D, GLP-1 RA is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin.

AstraZeneca is hopping aboard the pickleball craze as its serves up a new marketing push for its asthma med Fasenra. | ...

While the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...

Tirzepatide is approved by the Food and Drug Administration (FDA) for treating type 2 diabetes and obesity, akin to other GLP ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...